[{"Assets_0_Q3_USD":222358000.0,"CommonStockSharesOutstanding_0_Q3_shares":33224000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-11530000.0,"NetIncomeLoss_1_Q3_USD":98860000.0,"NetIncomeLoss_3_Q3_USD":79490000.0,"StockholdersEquity_0_Q3_USD":191409000.0,"EarningsPerShareBasic_1_Q3_USD":2.99,"EarningsPerShareBasic_3_Q3_USD":2.41,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":33112000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":33015000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]